BioCentury
ARTICLE | Strategy

M&A adds fuel to the fire

April 14, 2003 7:00 AM UTC

Big Spenders

Many biotechs making the shift from toolkit models or early stage research to more fully integrated product development companies are doing so with the help of mergers and acquisitions. But while M&A adds pieces of the value chain, it also can add significant costs. Thus, it bears repeating that acquirers need to move quickly to retain the assets they need and divest those they don't. ...